Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis EUR 750M Bond (1.700%, 2018–2038) by Year
EUR 750M Bond (1.700%, 2018–2038) ($M)
Novartis EUR 750M Bond (1.700%, 2018–2038): $874M in FY2025, up 12.9% from a year earlier.
Latest, FY2025
874
Period ended Dec 31, 2025
Change on a year earlier
+12.9%
774 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 19.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | EUR 750M Bond (1.700%, 2018–2038) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 874 | +12.9% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 774 | -6.0% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 823 | +3.9% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2022 | Dec 31, 2022 | 792 | -5.7% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2021 | Dec 31, 2021 | 840 | -8.0% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2020 | Dec 31, 2020 | 913 | +9.7% | Novartis Form 20-F (0001370368-22-000010) ↗ |
| FY2019 | Dec 31, 2019 | 832 | -2.0% | Novartis Form 20-F (0001370368-21-000006) ↗ |
| FY2018 | Dec 31, 2018 | 849 | – | Novartis Form 20-F (0001370368-20-000003) ↗ |
Cite this data
StockData. (2026). Novartis EUR 750M Bond (1.700%, 2018–2038) ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bond-6-a1-700eur750million20182038ofnovartisfinan
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.